Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus

Abstract Ischemia reperfusion (IR) injury may be attenuated through succinate dehydrogenase (SDH) inhibition by dimethyl malonate (DiMAL). Whether SDH inhibition yields protection in diabetic individuals and translates into human cardiac tissue remain unknown. In isolated perfused hearts from 24 wee...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nichlas Riise Jespersen, Marie Vognstoft Hjortbak, Thomas Ravn Lassen, Nicolaj Brejnholt Støttrup, Jacob Johnsen, Pernille Tilma Tonnesen, Steen Larsen, Hans-Henrik Kimose, Hans Erik Bøtker
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cb3202da68854c63bc7f4b39308a071c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cb3202da68854c63bc7f4b39308a071c
record_format dspace
spelling oai:doaj.org-article:cb3202da68854c63bc7f4b39308a071c2021-12-02T17:44:55ZCardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus10.1038/s41598-020-67247-42045-2322https://doaj.org/article/cb3202da68854c63bc7f4b39308a071c2020-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-67247-4https://doaj.org/toc/2045-2322Abstract Ischemia reperfusion (IR) injury may be attenuated through succinate dehydrogenase (SDH) inhibition by dimethyl malonate (DiMAL). Whether SDH inhibition yields protection in diabetic individuals and translates into human cardiac tissue remain unknown. In isolated perfused hearts from 24 weeks old male Zucker diabetic fatty (ZDF) and age matched non-diabetic control rats and atrial trabeculae from patients with and without diabetes, we compared infarct size, contractile force recovery and mitochondrial function. The cardioprotective effect of a 10 minutes DiMAL administration prior to global ischemia and ischemic preconditioning (IPC) was evaluated. In non-diabetic hearts exposed to IR, DiMAL 0.1 mM reduced infarct size compared to IR (55 ± 7% vs. 69 ± 6%, p < 0.05). Mitochondrial respiration was reduced by DiMAL 0.6 mM compared to sham and DiMAL 0.1 mM (p < 0.05). In diabetic hearts an increased concentration of DiMAL (0.6 mM) was required for protection compared to IR (64 ± 13% vs. 79 ± 8%, p < 0.05). Mitochondrial function remained unchanged. In trabeculae from humans without diabetes, IPC and DiMAL improved contractile force recovery compared to IR (43 ± 12% and 43 ± 13% vs. 23 ± 13%, p < 0.05) but in patients with diabetes only IPC provided protection compared to IR (51 ± 15% vs. 21 ± 8%, p < 0.05). Neither IPC nor DiMAL modulated mitochondrial respiration in patients. Cardioprotection by SDH inhibition is possible in human tissue, but depends on diabetes status. The narrow therapeutic range and discrepancy in respiration between experimental and human studies may limit clinical translation.Nichlas Riise JespersenMarie Vognstoft HjortbakThomas Ravn LassenNicolaj Brejnholt StøttrupJacob JohnsenPernille Tilma TonnesenSteen LarsenHans-Henrik KimoseHans Erik BøtkerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nichlas Riise Jespersen
Marie Vognstoft Hjortbak
Thomas Ravn Lassen
Nicolaj Brejnholt Støttrup
Jacob Johnsen
Pernille Tilma Tonnesen
Steen Larsen
Hans-Henrik Kimose
Hans Erik Bøtker
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
description Abstract Ischemia reperfusion (IR) injury may be attenuated through succinate dehydrogenase (SDH) inhibition by dimethyl malonate (DiMAL). Whether SDH inhibition yields protection in diabetic individuals and translates into human cardiac tissue remain unknown. In isolated perfused hearts from 24 weeks old male Zucker diabetic fatty (ZDF) and age matched non-diabetic control rats and atrial trabeculae from patients with and without diabetes, we compared infarct size, contractile force recovery and mitochondrial function. The cardioprotective effect of a 10 minutes DiMAL administration prior to global ischemia and ischemic preconditioning (IPC) was evaluated. In non-diabetic hearts exposed to IR, DiMAL 0.1 mM reduced infarct size compared to IR (55 ± 7% vs. 69 ± 6%, p < 0.05). Mitochondrial respiration was reduced by DiMAL 0.6 mM compared to sham and DiMAL 0.1 mM (p < 0.05). In diabetic hearts an increased concentration of DiMAL (0.6 mM) was required for protection compared to IR (64 ± 13% vs. 79 ± 8%, p < 0.05). Mitochondrial function remained unchanged. In trabeculae from humans without diabetes, IPC and DiMAL improved contractile force recovery compared to IR (43 ± 12% and 43 ± 13% vs. 23 ± 13%, p < 0.05) but in patients with diabetes only IPC provided protection compared to IR (51 ± 15% vs. 21 ± 8%, p < 0.05). Neither IPC nor DiMAL modulated mitochondrial respiration in patients. Cardioprotection by SDH inhibition is possible in human tissue, but depends on diabetes status. The narrow therapeutic range and discrepancy in respiration between experimental and human studies may limit clinical translation.
format article
author Nichlas Riise Jespersen
Marie Vognstoft Hjortbak
Thomas Ravn Lassen
Nicolaj Brejnholt Støttrup
Jacob Johnsen
Pernille Tilma Tonnesen
Steen Larsen
Hans-Henrik Kimose
Hans Erik Bøtker
author_facet Nichlas Riise Jespersen
Marie Vognstoft Hjortbak
Thomas Ravn Lassen
Nicolaj Brejnholt Støttrup
Jacob Johnsen
Pernille Tilma Tonnesen
Steen Larsen
Hans-Henrik Kimose
Hans Erik Bøtker
author_sort Nichlas Riise Jespersen
title Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
title_short Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
title_full Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
title_fullStr Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
title_full_unstemmed Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
title_sort cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/cb3202da68854c63bc7f4b39308a071c
work_keys_str_mv AT nichlasriisejespersen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT marievognstofthjortbak cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT thomasravnlassen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT nicolajbrejnholtstøttrup cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT jacobjohnsen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT pernilletilmatonnesen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT steenlarsen cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT hanshenrikkimose cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
AT hanserikbøtker cardioprotectiveeffectofsuccinatedehydrogenaseinhibitioninratheartsandhumanmyocardiumwithandwithoutdiabetesmellitus
_version_ 1718379613458006016